Longeveron Congratulates Co-Founder and Chairman Dr. Joshua Hare on Induction as Fellow of National Academy of Inventors
Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today that Chairman, Co-founder and Chief Science Officer Joshua Hare, MD, FACC, has been inducted as a fellow of the prestigio...
Amesite’s CEO Ann Marie Sastry Special Guest in ARK Invest’s Podcast
Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for education, business, and government markets, announces today that Dr. Ann Marie Sastry participated as a special guest in an ARK Invest Podcast hosted by Cathie Wood of ARK...
The Mirage of Employment Data: Why Federal Policy May Lead Us Toward Deflation
The latest non-farm payroll data has sparked much debate about the direction of our economy. However, an argument could be made that we should be cautious about using such indicators as a gauge for financial policy. A closer examination of these numbers, particularly in light of recent pandemic-r...
Investor Anxiety Peaks as VIX Index Skyrockets Amid Fed Rate Hike Concerns
On Thursday, we saw better-than-expected economic data that further fueled market expectations of rate hikes. June witnessed an impressive addition of 497,000 new payrolls, well above the forecast.
Strong US Jobs Data Spooks Markets: Expectations for Further Rate Hikes Loom
The US labor market has shown continued signs of resilience, as evidenced by the latest job figures.
Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
SHELTON, CONNECTICUT - July 6, 2023 - NanoViricides, Inc. (NYSE American: NNVC) reports that the clinical trial of its broad-spectrum antiviral drug NV-CoV-2 is progressing satisfactorily.
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
DSS, Inc. (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend of Impact Biomedical Inc.to DSS Inc. sharehold...